Mendus AB (publ) (STO:IMMU)
Sweden · Delayed Price · Currency is SEK 5.40
+0.10 (1.89%)
Oct 13, 2026, 11:35 AM CET
Mendus AB Market Cap
Mendus AB has a market cap or net worth of 358.1 million as of October 12, 2026. It is the 32,985th most valuable company in the world and the 443rd biggest in Sweden. Its market cap has increased by 19.43% in one year.
Market Cap
358.10M
Enterprise Value
316.14M
Revenue
n/a
Global Rank
Country Rank
#443 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 22, 2013, Mendus AB's market cap has increased from 117.09M to 358.10M, an increase of 205.84%. That is a compound annual growth rate of 8.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 358.10M | 4.43% |
| Dec 30, 2025 | 342.91M | -12.71% |
| Dec 30, 2024 | 392.86M | -12.97% |
| Dec 29, 2023 | 451.43M | -6.06% |
| Dec 30, 2022 | 480.56M | -43.76% |
| Dec 30, 2021 | 854.43M | -30.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AlzeCure Pharma AB | 932.19M |
| FluoGuide | 518.27M |
| Xspray Pharma AB | 507.36M |
| Cantargia AB | 386.26M |
| Sprint Bioscience AB | 385.13M |
| Corline Biomedical AB | 358.02M |
| Intervacc AB | 302.30M |
| Xbrane Biopharma AB | 287.44M |